Jeremy Rock

13PUBLICATIONS
40CO-AUTHORS
Tissue engineeringBacteriologyMedical infection agents (incl. prions)Gene and molecular therapyMycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 26, 2026
Erratum for Theriault et al., "Utilization of a CRISPRi-based <i>ex vivo</i> challenge model to reveal temporally dependent gene essentiality in intracellular <i>Mycobacterium tuberculosis</i>".

|May 19, 2026
Transcription attenuation amplifies collateral vulnerabilities in rifampicin-resistant Mycobacterium tuberculosis.

|Apr 20, 2026
Utilization of a CRISPRi-based <i>ex vivo</i> challenge model to reveal temporally dependent gene essentiality in intracellular <i>Mycobacterium tuberculosis</i>.

|Apr 07, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation.

Dirk Schnappinger, Steven J Berthel, Helena I M Boshoff

|Jan 16, 2026
An activator of a two-component system controls cell separation and intrinsic drug resistance in <i><i>Mycobacterium tuberculosis</i></i>.

Liam D McDonough, Shuqi Li, Vanisha Munsamy-Govender

|Dec 03, 2025
Transcription co-inhibition alters drug resistance evolution and enhances Mycobacterium tuberculosis clearance from granulomas.

Barbara Bosch, Vanisha Munsamy-Govender, Jansy Sarathy

Pageof 3

Frequent Collaborators

4 joint publications

Dirk Schnappinger

3 joint publications

Vanisha Munsamy-Govender

3 joint publications

Elizabeth A Campbell

2 joint publications

David G Russell